Want to see KR:044820 full AI Analyst Report?
Top Page
Cosmax BTI Inc.
(044820)
Select Model
Select Model
Rating:65Neutral
Price Target:
₩24,349.00
Action:N/A
Date:10/28/26
The score is driven primarily by improving operating performance (stronger growth and margin rebound) but held back by high leverage and weak/volatile free-cash-flow conversion. Valuation is a major offset (very low P/E and solid dividend yield), while technical signals are currently soft with negative momentum indicators.
Positive Factors
Improving revenue and profitability
Revenue growth and a substantial margin rebound indicate stronger operating execution and improved economics in the core business. If sustained, the combination can support reinvestment, strengthen earnings capacity, and provide a more durable base for growth over the next several quarters.
Negative Factors
Elevated leverage
Debt remains high relative to equity despite recent improvement, leaving the company more vulnerable if demand weakens or margins compress. Higher leverage can constrain capital allocation, increase financial risk, and reduce the flexibility available to fund growth or absorb operating setbacks.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving revenue and profitability
Revenue growth and a substantial margin rebound indicate stronger operating execution and improved economics in the core business. If sustained, the combination can support reinvestment, strengthen earnings capacity, and provide a more durable base for growth over the next several quarters.
Read all positive factors
Cosmax BTI Inc. (044820) vs. SPDR S&P 500 ETF (SPY)
Market Cap
₩209.73B
Dividend Yield3.55%
Average Volume (3M)22.44K
Price to Earnings (P/E)3.8
Beta (1Y)0.40
Revenue Growth25.12%
EPS Growth295.70%
CountryKR
Employees341
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)5799.66
Shares Outstanding9,603,921
10 Day Avg. Volume22,941
30 Day Avg. Volume22,440
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.47
Price to Sales (P/S)0.20
P/FCF Ratio28.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cosmax BTI Inc. Business Overview & Revenue Model
Company Description
Cosmax BTI, Inc., established in 1992 and headquartered in Seongnam, South Korea, specializes in the development, manufacturing, and distribution of a diverse array of items. These include cosmetic products, dietary supplements, pharmaceutical goo...
Cosmax BTI Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
62
Positive
Cash Flow
45
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 771.33B | 645.21B | 597.63B | 628.60B | 617.40B | 576.00B |
| Gross Profit | 158.27B | 129.00B | 112.27B | 104.94B | 88.17B | 91.96B |
| EBITDA | 67.54B | 54.46B | 71.65B | 48.24B | 33.82B | 41.08B |
| Net Income | 63.78B | 29.21B | 16.46B | 9.06B | -6.53B | 14.13B |
Balance Sheet | ||||||
| Total Assets | 1.12T | 1.01T | 953.90B | 878.27B | 936.14B | 954.66B |
| Cash, Cash Equivalents and Short-Term Investments | 83.50B | 107.18B | 80.25B | 78.71B | 95.46B | 87.78B |
| Total Debt | 506.15B | 513.95B | 507.56B | 462.94B | 466.29B | 471.05B |
| Total Liabilities | 749.79B | 710.65B | 672.67B | 625.88B | 610.37B | 612.77B |
| Stockholders Equity | 324.19B | 275.54B | 251.69B | 231.83B | 300.99B | 308.16B |
Cash Flow | ||||||
| Free Cash Flow | 15.84B | 4.57B | 2.31B | 2.07B | 16.22B | -9.34B |
| Operating Cash Flow | 52.05B | 35.17B | 23.84B | 29.78B | 29.96B | -22.35M |
| Investing Cash Flow | -19.53B | -12.68B | -32.09B | -39.01B | 544.38M | -46.74B |
| Financing Cash Flow | -46.67B | -1.10B | 6.73B | -7.67B | -23.55B | 33.09B |
Cosmax BTI Inc. Technical Analysis
Negative
―
Price Trends
23848.00
Negative
21779.30
Positive
18614.68
Positive
Market Momentum
-474.16
Positive
40.19
Neutral
42.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:044820, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 23150.00, equal to the 50-day MA of 23848.00, and equal to the 200-day MA of 18614.68, indicating a neutral trend. The MACD of -474.16 indicates Positive momentum. The RSI at 40.19 is Neutral, neither overbought nor oversold. The STOCH value of 42.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:044820.
Cosmax BTI Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ₩348.02B | 6.12 | ― | 5.34% | 19.89% | 21.27% | |
77 Outperform | ₩259.08B | 6.74 | ― | 0.50% | 22.88% | 24.47% | |
65 Neutral | ₩209.73B | 3.78 | ― | 3.55% | 25.12% | 295.70% | |
60 Neutral | ₩2.80T | 14.58 | ― | 1.34% | 15.81% | 197.32% | |
56 Neutral | ₩2.66T | 14.36 | ― | 0.77% | 12.57% | 90.44% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | ₩204.92B | -243.15 | ― | 0.77% | -8.83% | -111.22% |
* General Sector Average
KR:044820
Cosmax BTI Inc.
21,950.00
8,377.02
61.72%
KR:003350
Hankook Cosmetics Manufacturing Co., Ltd
11,910.00
1,153.90
10.73%
KR:092730
NeoPharm Co., Ltd.
22,250.00
5,667.80
34.18%
KR:161890
KOLMAR KOREA CO. LTD
112,500.00
36,335.77
47.71%
KR:192820
COSMAX, Inc.
247,000.00
45,791.95
22.76%
KR:200130
KolmarBNH Co., Ltd.
7,410.00
-6,368.25
-46.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.